I am a
Home I AM A Search Login

Papers of the Week


Papers: 27 Mar 2021 - 2 Apr 2021


Human Studies, Pharmacology/Drug Development

PAIN TYPE:
Migraine/Headache


2021 Mar 25


J Headache Pain


22


1

Early onset of effect following galcanezumab treatment in patients with previous preventive medication failures.

Authors

Schwedt TJ, Kuruppu DK, Dong Y, Standley K, Yunes-Medina L, Pearlman E
J Headache Pain. 2021 Mar 25; 22(1):15.
PMID: 33765912.

Abstract

Galcanezumab is a monoclonal antibody (mAb) that binds calcitonin gene-related peptide (CGRP) and is indicated for the preventive treatment of migraine. Galcanezumab demonstrated early onset of effect in patients with migraine but it is unknown whether the same holds true for patients who have not benefited from multiple prior migraine preventives.